Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jouve

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Thrombosis and Haemostasis : JTH|February 21, 2018
Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations: commentR Marlu, T Jouve, B Polack, et al.
Medecine Et Maladies Infectieuses|October 22, 2016
Lactobacillus bacteremia: Pathogen or prognostic marker?B Franko, P Fournier, T Jouve, et al.
BMC Nephrology|September 22, 2018
Use of rituximab as an induction therapy in anti-glomerular basement-membrane diseaseM Heitz, P L Carron, G Clavarino, et al.
Thrombosis Research|June 12, 2018
Corrigendum to "Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation" [Thromb. Res. 166 (2018) 113-121]R Marlu, P Malvezzi, L Seyve, et al.
Thrombosis Research|May 11, 2018
Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generationR Marlu, P Malvezzi, L Seyve, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 31, 2025
Determinants of virological outcomes in kidney transplant recipients treated with maribavir for refractory cytomegalovirus infectionN Kasriel, S Alain, I Benotmane, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Thrombosis and Haemostasis : JTH|February 21, 2018
Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations: commentR Marlu, T Jouve, B Polack, et al.
Medecine Et Maladies Infectieuses|October 22, 2016
Lactobacillus bacteremia: Pathogen or prognostic marker?B Franko, P Fournier, T Jouve, et al.
BMC Nephrology|September 22, 2018
Use of rituximab as an induction therapy in anti-glomerular basement-membrane diseaseM Heitz, P L Carron, G Clavarino, et al.
Thrombosis Research|June 12, 2018
Corrigendum to "Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation" [Thromb. Res. 166 (2018) 113-121]R Marlu, P Malvezzi, L Seyve, et al.
Thrombosis Research|May 11, 2018
Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generationR Marlu, P Malvezzi, L Seyve, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 31, 2025
Determinants of virological outcomes in kidney transplant recipients treated with maribavir for refractory cytomegalovirus infectionN Kasriel, S Alain, I Benotmane, et al.
Pageof 1